Full IIHS safety ratings for 3 popular large SUVs
Large SUVs struggle in IIHS tests
June 06, 2024 00:01 ET | Insurance Institute for Highway Safety
ARLINGTON, Va., June 06, 2024 (GLOBE NEWSWIRE) -- For drivers of large SUVs, their imposing size comes with a sense of security. But some models are safer than others, new ratings from the Insurance...
Rhythm_Logo_RGB_JPG-registration mark.jpg
Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024
June 03, 2024 16:02 ET | Rhythm Pharmaceuticals, Inc.
Rhythm presents first-ever hypothalamic obesity patient-reported experiences with hyperphagia and positive changes in energy and sleep at ENDO2024
Rhythm_Logo_RGB_JPG-registration mark.jpg
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
June 03, 2024 08:02 ET | Rhythm Pharmaceuticals, Inc.
RYTM CEO at David Meeker at Goldman Sachs Global Healthcare Conference June 10.
QIAGEN expands QIAst
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care
June 03, 2024 02:00 ET | QIAGEN N.V.
Germantown, Maryland, and Venlo, the Netherlands, June 03, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Gastrointestinal...
BB Logo_Tagline_FullColor.png
Additional Data Showing Acoramidis Increases Serum Transthyretin Which is Associated with Improved Cardiovascular Outcomes Presented at ISA from BridgeBio Pharma’s Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
May 29, 2024 16:01 ET | BridgeBio Pharma, Inc.
- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular...
Canary Logo.jpg
Canary Medical’s Smart Spine Lumbar Cartridge Granted FDA “Breakthrough Device” Designation
May 29, 2024 08:00 ET | Canary Medical
Smart Spine Lumbar Cartridge is the fourth Canary Medical product to receive Breakthrough Designation through the FDA Breakthrough Devices ProgramLumbar Cartridge represents Canary Medical’s first...
GRANTIERRA_LOGO2018-RGB.png
Gran Tierra Energy Inc. Announces Test Results of Arawana-J1 Discovery and Provides Ecuador Exploration Update
May 28, 2024 06:00 ET | Gran Tierra Energy Inc.
CALGARY, Alberta, May 28, 2024 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) today announced an operational update. All dollar...
ICG.png
ICG: Final Results for the financial year ended 31 March 2024
May 28, 2024 02:00 ET | Intermediate Capital Group plc
    Delivering multiple levers of growth  Highlights AUM of $98bn1; fee-earning AUM of $70bn, up 11%2 compared to FY23 and five-year annualised growth of 17%2Fundraising of $13.0bn, including 31%...
Karolinska Developme
Karolinska Development invests in BOOST Pharma, expanding its portfolio
May 28, 2024 02:00 ET | Karolinska Development AB (publ)
STOCKHOLM, SWEDEN – May 28, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the company has invested in BOOST Pharma – a company based on research from Karolinska...
Class 1 Nickel and Technologies Ltd.
Class 1 Nickel Updates Resource Estimate on High-Grade Alexo North Nickel Sulphide Deposit – Significant Increases in Indicated Resources Over the 2020 Estimate
May 22, 2024 09:22 ET | Class 1 Nickel and Technologies Limited
Indicated Resources (open pit and underground*) of 42,600 t at 0.92% Ni (864k lbs Ni) – 63% increase in Indicated tonnes and 8% increase in nickel pounds.Inferred Resources (open pit and underground*)...